What are the causes of thrombosis in patients with nephrotic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Thrombosis in Nephrotic Syndrome

Nephrotic syndrome creates a severe hypercoagulable state through multiple mechanisms, with urinary loss of antithrombotic proteins being the primary driver, compounded by increased hepatic synthesis of procoagulant factors and alterations in platelet function. 1

Primary Pathophysiologic Mechanisms

Loss of Natural Anticoagulants

  • Urinary loss of antithrombin III, protein C, and protein S reduces the body's natural anticoagulant defenses, creating the fundamental prothrombotic imbalance 1
  • Higher than usual heparin dosing is required in nephrotic syndrome specifically due to antithrombin III urinary loss 2
  • The severity of proteinuria directly correlates with the degree of anticoagulant protein loss 3

Hepatic Overproduction of Procoagulant Factors

  • The liver compensates for hypoalbuminemia by increasing protein synthesis, which disproportionately increases production of procoagulant factors including fibrinogen, factor V, factor VIII, and von Willebrand factor 4
  • This creates an imbalance favoring thrombosis over natural anticoagulation 3

Hypoalbuminemia as the Critical Risk Factor

  • Serum albumin <20-25 g/L is the most significant independent predictor of thrombotic risk, particularly when <20 g/dL 1, 3
  • Hypoalbuminemia affects the balance between pro-coagulant and anti-coagulant factors 3

Secondary Contributing Factors

Disease-Specific Risk

  • Membranous glomerulonephritis carries a particularly high risk of thromboembolic events compared to other causes of nephrotic syndrome 2, 5
  • The type of underlying glomerulonephritis significantly influences thrombotic risk 3, 5

Severity of Proteinuria

  • Proteinuria >10 g/day substantially increases thrombotic risk independent of albumin levels 1
  • Severe proteinuria indicates greater urinary loss of protective anticoagulant proteins 6

Additional Clinical Risk Factors

The following factors compound the baseline hypercoagulable state 1:

  • Body mass index >35 kg/m² 1
  • Heart failure (NYHA class III or IV) 1
  • Recent orthopedic or abdominal surgery 1
  • Prolonged immobilization 1
  • Previous thromboembolic episodes 5

Inherited Thrombophilia

  • Congenital protein S deficiency or other inherited thrombophilic conditions can act as critical additional risk factors when combined with nephrotic syndrome 7
  • Genetic predisposition to thrombosis may amplify the acquired hypercoagulable state 5

Alterations in Platelet Function

  • Platelet hyperaggregability and increased platelet counts contribute to the prothrombotic state 4
  • Changes in platelet function occur secondary to the metabolic derangements of nephrotic syndrome 4

Clinical Implications

Risk Stratification Algorithm

High-risk patients requiring prophylactic anticoagulation include those with 1:

  • Serum albumin <20-25 g/L PLUS any of the following:
    • Proteinuria >10 g/day
    • BMI >35 kg/m²
    • NYHA class III-IV heart failure
    • Recent major surgery
    • Prolonged immobilization
    • Membranous glomerulonephritis

Common Pitfall

  • Do not wait for a thrombotic event to occur before considering anticoagulation in patients meeting high-risk criteria 1
  • The decision to anticoagulate prophylactically must balance thrombotic risk against bleeding risk on a case-by-case basis, but when albumin is <20-25 g/L with additional risk factors and no absolute bleeding contraindications, the decision favors anticoagulation 1, 5

References

Guideline

Anticoagulation in Nephrotic Syndrome with Very Low Albumin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypercoagulability and nephrotic syndrome.

Current vascular pharmacology, 2014

Research

Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum.

Journal of the American Society of Nephrology : JASN, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.